Skip to content

Alfuzosin

Alfuzosin is an alpha1-adrenergic blocker used for lower urinary tract symptoms associated with benign prostatic hyperplasia.

Uroxatral

Benign Prostatic Hyperplasia

10mg

Developed to mitigate bladder neck resistance to support peak urinary stream and alleviate voiding difficulties.

From$1.60/ tabletView

Key points

  • Alfuzosin relaxes smooth muscle in the prostate and bladder neck.
  • Uroxatral is an extended-release tablet identity.

The Uroxatral record connects alfuzosin with benign prostatic hyperplasia. Extended-release wording is clinically meaningful because it describes how the tablet releases medicine. Dizziness and postural blood-pressure falls follow from alpha1 blockade and are specific to understanding this ingredient.

Further reading